London’s Bitfount raises €6.8 million to interrupt down medical analysis information silos with federated AI community

HealthTech platform Bitfount, a British federated AI platform innovating medical analysis collaboration, has secured €6.8 million in Collection A funding to scale its privacy-preserving community throughout healthcare methods globally.

Parkwalk Advisors, Ahren Innovation Capital, Tempo Ventures, Foresight Group, and Portfolio Ventures participated within the spherical.

“Medical analysis is damaged by information silos,” stated Dr Blaise Thomson, CEO and Co-founder of Bitfount. “We’ve constructed the lacking infrastructure that lets organisations collaborate securely with out the unattainable alternative between innovation and privateness. This funding strikes us additional in direction of our imaginative and prescient of unlocking the worth of delicate information for the good thing about humankind, and is a testomony to the good work being finished by the Bitfount group and to the help of our ecosystem companions.”

Based in 2020, Bitfount goals to democratise federated AI infrastructure for medical analysis, enabling safe collaboration with out information sharing. Co-founded by Dr Blaise Thomson (former Chief Architect for Siri Understanding at Apple and head of Apple’s Cambridge workplace) and Dr Naaman Tammuz, the corporate’s platform connects healthcare suppliers, pharmaceutical firms, and CROs via privacy-preserving AI networks.

Healthcare suppliers and pharmaceutical firms can collaborate to enhance medical analysis with out ever sharing uncooked affected person information. The platform works throughout each digital well being data (EHR) and medical imaging information – a novel functionality that the corporate says units it other than platforms restricted to text-based evaluation alone.

It streamlines trial lifecycles by accelerating affected person recruitment, decreasing display failure charges, and enabling data-driven website feasibility assessments – all whereas sustaining full information sovereignty. AI mannequin growth is equally accelerated.

The funding comes because the UK authorities unveils unprecedented help for medical analysis via its 10 Yr Well being Plan, introduced in June 2025. The plan goals to slash industrial trial set-up instances from 250 days to 150 days or much less by March 2026 and place the UK as a worldwide vacation spot for medical trials.

Nonetheless, Bitfount says attaining these targets requires addressing basic infrastructure challenges – exactly what Bitfount’s federated AI platform goals to ship by enabling safe collaboration with out the data-sharing bottlenecks which have traditionally slowed UK medical analysis.

“Information sharing for medical analysis is usually hampered by privateness considerations, fragmented methods, and regulatory boundaries. I’ve skilled this first-hand a number of instances throughout high-profile collaborations with each trade companions and tutorial establishments,” stated Professor Pearse Keane, Advisor Ophthalmologist at Moorfields Eye Hospital and Professor of Synthetic Medical Intelligence at College Faculty London. “Federated information science and AI provide a transformative resolution by enabling insights to be found and shared throughout establishments with out the necessity for sharing any uncooked information. This not solely protects affected person confidentiality however, by bettering the pace, variety and effectivity of medical trials, can dramatically speed up medical discoveries which profit thousands and thousands of sufferers.“

The platform’s no-code desktop utility can reportedly be deployed throughout any healthcare setting – from main hospital methods to small group clinics. This method addresses the €86 billion AI for Healthcare and Life Sciences market, the place information privateness considerations have restricted AI adoption.

In a validation research carried out with Moorfields Eye Hospital for a trial in Dry Age-Associated Macular Degeneration (Dry AMD), the group demonstrated a discount in display failure charges from 60% for conventional EHR-based searches alone, to only 14% when EHR search was mixed with AI-based OCT picture evaluation, whereas nonetheless figuring out over 600 eligible sufferers at that single hospital.

“We’re excited to again Blaise Thomson, who beforehand efficiently bought a Parkwalk portfolio firm to Apple, and the remainder of the formidable Bitfount group,” stated Neil Cameron, Funding Director at Parkwalk. “Bitfount was conceived throughout Blaise’s time at Apple as a know-how that might overcome lots of the inner and exterior collaboration challenges confronted by organisations with confidential information and safety considerations. Bitfount’s preliminary concentrate on medical trials is an space ideally suited to one of these AI utility.”

The funding will speed up product growth and develop partnerships with industrial and tutorial AI mannequin growth organisations, significantly focusing on pharmaceutical firms and medical analysis organisations (CROs).

Bitfount plans to increase its platform capabilities throughout the complete medical analysis lifecycle, from protocol design via regulatory approval.